Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - New York Stock Exchange, Inc. - US7616241052 - Common Stock - Currency: USD

42  -0.54 (-1.27%)

After market: 42 0 (0%)

Fundamental Rating

6

Taking everything into account, REX scores 6 out of 10 in our fundamental rating. REX was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. REX has an excellent financial health rating, but there are some minor concerns on its profitability. REX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year REX was profitable.
In the past year REX had a positive cash flow from operations.
In the past 5 years REX has always been profitable.
REX had a positive operating cash flow in each of the past 5 years.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

REX's Return On Assets of 8.08% is fine compared to the rest of the industry. REX outperforms 76.53% of its industry peers.
REX has a Return On Equity (10.38%) which is in line with its industry peers.
REX has a better Return On Invested Capital (7.40%) than 60.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for REX is significantly below the industry average of 25.88%.
The last Return On Invested Capital (7.40%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.08%
ROE 10.38%
ROIC 7.4%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

REX has a Profit Margin (9.05%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of REX has grown nicely.
REX has a worse Operating Margin (10.01%) than 61.97% of its industry peers.
In the last couple of years the Operating Margin of REX has grown nicely.
The Gross Margin of REX (14.24%) is worse than 68.08% of its industry peers.
REX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.01%
PM (TTM) 9.05%
GM 14.24%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

REX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
REX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, REX has less shares outstanding
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

REX has an Altman-Z score of 5.93. This indicates that REX is financially healthy and has little risk of bankruptcy at the moment.
REX has a Altman-Z score of 5.93. This is amongst the best in the industry. REX outperforms 91.55% of its industry peers.
There is no outstanding debt for REX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.93
ROIC/WACC0.71
WACC10.36%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 8.64. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
REX's Current ratio of 8.64 is amongst the best of the industry. REX outperforms 96.24% of its industry peers.
A Quick Ratio of 8.01 indicates that REX has no problem at all paying its short term obligations.
REX's Quick ratio of 8.01 is amongst the best of the industry. REX outperforms 96.24% of its industry peers.
Industry RankSector Rank
Current Ratio 8.64
Quick Ratio 8.01
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for REX have decreased by -5.19% in the last year.
The Earnings Per Share has been growing by 54.06% on average over the past years. This is a very strong growth
REX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.91%.
REX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-45.69%
Revenue 1Y (TTM)-22.91%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-15.66%

3.2 Future

Based on estimates for the next years, REX will show a decrease in Earnings Per Share. The EPS will decrease by -4.03% on average per year.
Based on estimates for the next years, REX will show a quite strong growth in Revenue. The Revenue will grow by 10.00% on average per year.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.77 indicates a correct valuation of REX.
REX's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.03. REX is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 26.83, REX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REX indicates a slightly more expensive valuation: REX is more expensive than 64.32% of the companies listed in the same industry.
REX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.77
Fwd PE 26.83
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of REX indicates a rather cheap valuation: REX is cheaper than 95.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.05
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

REX has a very decent profitability rating, which may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

REX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (5/21/2025, 8:04:00 PM)

After market: 42 0 (0%)

42

-0.54 (-1.27%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-25 2025-08-25/bmo
Inst Owners85.03%
Inst Owner Change-1.12%
Ins Owners13.72%
Ins Owner Change7.05%
Market Cap698.04M
Analysts80
Price Target51 (21.43%)
Short Float %4.21%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.27%
Min EPS beat(2)89.77%
Max EPS beat(2)122.77%
EPS beat(4)3
Avg EPS beat(4)63.66%
Min EPS beat(4)-1.27%
Max EPS beat(4)122.77%
EPS beat(8)6
Avg EPS beat(8)83.77%
EPS beat(12)10
Avg EPS beat(12)106.16%
EPS beat(16)13
Avg EPS beat(16)892.42%
Revenue beat(2)2
Avg Revenue beat(2)6.3%
Min Revenue beat(2)3.38%
Max Revenue beat(2)9.23%
Revenue beat(4)2
Avg Revenue beat(4)1.92%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)9.23%
Revenue beat(8)5
Avg Revenue beat(8)4.27%
Revenue beat(12)8
Avg Revenue beat(12)3%
Revenue beat(16)11
Avg Revenue beat(16)3.53%
PT rev (1m)-12.66%
PT rev (3m)-16.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30.77%
EPS NY rev (1m)0%
EPS NY rev (3m)14.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.04%
Valuation
Industry RankSector Rank
PE 12.77
Fwd PE 26.83
P/S 1.09
P/FCF N/A
P/OCF 10.87
P/B 1.25
P/tB 1.25
EV/EBITDA 2.05
EPS(TTM)3.29
EY7.83%
EPS(NY)1.57
Fwd EY3.73%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)3.86
OCFY9.2%
SpS38.66
BVpS33.71
TBVpS33.71
PEG (NY)N/A
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 8.08%
ROE 10.38%
ROCE 9.61%
ROIC 7.4%
ROICexc 15.96%
ROICexgc 15.96%
OM 10.01%
PM (TTM) 9.05%
GM 14.24%
FCFM N/A
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 328.43%
Cap/Sales 11.1%
Interest Coverage 250
Cash Conversion 74.6%
Profit Quality N/A
Current Ratio 8.64
Quick Ratio 8.01
Altman-Z 5.93
F-Score7
WACC10.36%
ROIC/WACC0.71
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-45.69%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.91%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-15.66%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.55%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.84%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%